All Episodes
NEJM Interviews — 958 episodes · page 4 of 10
Do We Need New Covid-19 Vaccines?
NEJM Interview: Kushal Kadakia on the 21st Century Cures Act, Cures 2.0, and lessons from Covid-19 for medical product development.
Communicating Covid-19 Science
NEJM Interview: Dr. Abigail Friedman on policy approaches to combating adolescent vaping and helping adult smokers quit.
The Effects of Covid-19 on Children
NEJM Interview: Dr. Lois Lee on reductions in deaths from motor vehicle crashes among children and young adults and increases in firearm-related deaths.
Do the Tobacco Wars Offer Any Lessons for the Vaccine Wars?
NEJM Interview: Dr. Hilary Seligman on reforming the Supplemental Nutrition Assistance Program to reduce food insecurity in the United States.
Do We Need a Fourth Dose of Covid Vaccine?
NEJM Interview: Dr. Vikas Saini on the Choosing Wisely campaign and approaches for addressing low-value care.
Effectiveness of Covid-19 Vaccination in Children
NEJM Interview: Prof. Christopher Robertson on the outcomes and implications of cases in which patients sued hospitals for access to ivermectin.
Covid-19 — Why We Publish What We Do
NEJM Interview: Dr. Jorge Rodriguez on new U.S. legislation and the role of health care organizations in addressing digital divides.
Can We Make More Effective Covid-19 Vaccines?
NEJM Interview: Dr. Melissa Wachterman on cultural factors and financial incentives driving where people in the United States choose to die.
Making Covid-19 Vaccines Available around the World
NEJM Interview: Prof. Rachel Sachs on the balance between safeguarding access to high-quality care and constraining drug spending.
Using Our Covid-19 Experience to Develop Vaccines More Quickly
NEJM Interview: Prof. Michelle Mello on individual rights and state and federal powers to regulate health matters in the United States.
Understanding the Omicron Variant of SARS-CoV-2
NEJM Interview: Prof. Patricia Zettler on conflicts between state and federal law and access to mifepristone.
A New Antiviral against Covid-19
NEJM Interview: Dr. Lee Fleisher on building a resilient health care delivery system that can maintain high safety levels in times of crisis.
Covid-19 as an Endemic Disease
NEJM Interview: Dr. Joseph Graves, Jr. on socially defined races, human biologic variation, and disease.
Studying Long Covid
NEJM Interview: Dr. Tiffany Green on how economics can help guide public health policy.
Addressing the Omicron Variant of SARS-CoV-2
NEJM Interview: Dr. David Morens on the need for developing broadly protective coronavirus vaccines.
Crushing the Covid-19 Curve
NEJM Interview: Dr. L. Ebony Boulware on the importance of racial and ethnic diversification and increased focus on equity in clinical and translational research.
Covid-19 Takeaways at Podcast 100
NEJM Interview: Dr. Debra Weinstein on the pandemic’s effects on graduate medical education and what we can learn from them.
Covid-19 — The Outlook in Europe
NEJM Interview: Dr. Joshua Sharfstein on the haphazard organization of U.S. public health at the local, state, and federal levels.
Covid-19 Vaccination and the Omicron Variant
NEJM Interview: Dr. Jennifer Lucero on aversive racism as a contributor to structural racism in academic medicine.
A Potential New Agent to Treat Covid-19
NEJM Interview: Dr. Nicole Redvers on Covid-19 vaccination efforts in American Indian and Alaska Native communities.
How Much Protection Does Prior SARS-CoV-2 Infection Provide?
NEJM Interview: Dr. Jacob Bor on barriers to disseminating information about HIV treatment as a strategy for preventing virus transmission.
Waning Immunity against SARS-CoV-2
NEJM Interview: Dr. Janine Knudsen on the experience of safety-net health systems during the Covid-19 pandemic and supporting them moving forward.
The Omicron Variant of SARS-CoV-2
NEJM Interview: Dr. Colleen Barry on using public policy to improve population health.
What’s Gone Right in Our Battle against Covid-19
NEJM Interview: Dr. James Robinson on the aducanumab experience and the structural factors responsible for high drug prices in the United States.
The Legal Basis for Covid-19 Restrictions and Mandates
NEJM Interview: Dr. Rena Conti on strategies for regulating drug prices while promoting the development of new pharmaceuticals.
The Legal Basis for Covid-19 Restrictions and Mandates
Covid-19 in Brazil and New Evidence for Vaccinating Younger Children
NEJM Interview: Dr. Jeffrey Baker on a short-lived 1921 law that supported U.S. women and children.
Do We Have the Tools to End the Covid-19 Pandemic?
NEJM Interview: Dr. Elena Fuentes-Afflick on how focusing on the health and needs of subpopulations can advance population health.
A New Monoclonal Antibody for Covid-19 and Potential Vaccination for Children
NEJM Interview: Dr. Marshall Chin on gaps and inequities in the health care system’s approach to managing chronic diseases.
A New Look at Covid-19 Vaccine Boosters
NEJM Interview: Dr. Sasha Mallett on parenting during the Covid-19 pandemic as a person at high risk for infection and related harm.
Reporting on Covid-19
NEJM Interview: Prof. R. Alta Charo on a law that allows members of the public to file suit to stop abortions in Texas.
Are Covid-19 Vaccine Boosters Necessary?
NEJM Interview: Dr. Miguel Hernán on the use of observational data to inform public health and clinical care decisions.
Covid-19 and the Media
NEJM Interview: Jessica Leston on challenges facing the system that provides health care to American Indians and Alaska Natives.
Audio of Perspective Roundtable on Race in Medicine
Vaccine Efficacy and Boosters in Covid-19
NEJM Interview: Prof. Michelle Mello on legal cases related to Covid-19 emergency orders and the future of public health law.
New Evidence on SARS-CoV-2 Vaccine Boosters
NEJM Interview: Prof. Erin Fuse Brown on lessons from U.S. states that have enacted public option health plans
Protecting against Severe Disease and Transmission
NEJM Interview: Dr. Garth Rapeport on the development and implementation of a SARS-CoV-2 human challenge research program.
A New Round of Rising Covid-19 Numbers
NEJM Interview: Dr. Octavio Gómez-Dantés on translating the concept of human rights into health benefits for populations.
Assessing Vaccine Safety
NEJM Interview: Dr. Gil Rabinovici on the FDA’s controversial approval of a new treatment for Alzheimer’s disease.
Aspects of Covid-19 Immunity
NEJM Interview: Prof. Nicholas Bagley on the Supreme Court’s decision in California v. Texas
Monoclonal Antibodies and Booster Shots
NEJM Interview: Dr. Steven Phillips on questions and concerns about ongoing symptoms related to Covid-19 in many patients.
Looking Back and Looking Forward — Part 2
NEJM Interview: Dr. David Hunter on the complementary approaches and achievements of public health and clinical medicine.
Looking Back and Looking Forward — Part 1
NEJM Interview: Dr. Nathaniel Morris on the role of clinicians in programs that provide alternatives to incarceration.
The Impact of Covid-19 on Trainees and Junior Faculty
NEJM Interview: Dr. Lucy Marcil on the role of medical–financial partnerships in promoting individual and community health.
Monoclonal Antibodies and Vaccine Boosts
NEJM Interview: Dr. Suerie Moon on ways of making pandemic vaccines available to all, now and in the future.
How Well Are Covid-19 Vaccines Working?
NEJM Interview: Dr. Michele Andrasik on promoting Covid-19 vaccine access and uptake by building relationships.
Another New Covid-19 Vaccine
NEJM Interview: Dr. J. Michael McGinnis on supporting the evolution of a learning health system.
NEJM Interview: Prof. Sara Rosenbaum on policy and operational challenges related to advancing the Medicaid program.
Covid-19 in Children
NEJM Interview: Dr. Reshma Jagsi on the effects of Covid-19 on women in academic medicine and opportunities for promoting equity.
Treating Complications of Covid Vaccination
NEJM Interview: Dr. Anita Allen on progress in protecting health information privacy and the current direction of regulatory momentum.
Vaccinating Children
NEJM Interview: Dr. Cynthia Stuenkel on medical and policy progress and continued challenges in the field of women’s health.
Protecting the Immunosuppressed against Covid-19